%0 Journal Article
%T Counting Pharmacist Interventions Cannot Establish Pharmaceutical-Care Value Without Evidence Linking Delivered Care to Patient Benefit
%A Elena Petrova
%A Ravi Patel
%A Ingrid Larsen
%A Samuel Boateng
%J Annals of Pharmacy Practice and Pharmacotherapy
%@ 3062-4436
%D 2023
%V 3
%N 2
%R 10.51847/8zPVVc0TOx
%P 51-62
%X Pharmacist services are commonly evaluated using counts of interventions, recommendations, accepted recommendations, medication-related problems addressed, or other process measures. These indicators are important for describing workload, service reach, and implementation, but they occupy different positions in the causal sequence between pharmacist activity and patient benefit. A recommendation may never be accepted; an accepted recommendation may never be implemented; a medication modification may not persist; and a successfully implemented change may alter a medication-related intermediate outcome without improving an outcome that matters directly to the patient. Conversely, pharmacist interventions can generate patient benefit through mechanisms that do not require a medication change, including education, monitoring, adherence support, and communication. These possibilities make pharmaceutical-care value an attribution problem rather than a counting problem. This article develops an evidence-bounded causal interpretation of pharmacist-service evaluation by distinguishing service production, clinician uptake, actual medication modification, intermediate medication outcomes, and patient-important outcomes. Evidence from medication-review studies shows substantial heterogeneity across intervention components, implementation processes, endpoints, and observed effects. Studies that separately measure recommendation generation, acceptance, actioning, and implementation demonstrate that these stages cannot be treated as equivalent exposures. Medication-related outcomes such as drug-related problems, discrepancies, adherence, or medication burden provide stronger evidence of pathway activity than intervention counts, yet still require careful interpretation before patient benefit is attributed. Actual adverse drug events are also directly patient-important outcomes. Credible evaluation therefore depends on matching the strength of the causal claim to the level of outcome observed, the integrity of the implementation pathway, and the plausibility of competing explanations.
%U https://galaxypub.co/article/counting-pharmacist-interventions-cannot-establish-pharmaceutical-care-value-without-evidence-linkin-gzjfkh0uw3rzvxn